{"result": "Drotrecogin alfa (activated), also known as Xigris, is a medication that was available under the brand name Xigris. It was withdrawn from the market in 2011. Xigris served as the commercial form of drotrecogin alfa (activated), indicating that both names refer to the same product. The withdrawal applies universally to the product, regardless of the name it was marketed under.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: [\"DROTRECOGIN ALFA (ACTIVATED)\", \"XIGRIS\"]\nDescription List: [\"Drotrecogin alfa (activated) is another name for Xigris, which was withdrawn from the market in 2011\", \"Drotrecogin alfa (activated) is known in the market as Xigris, which was withdrawn in 2011\", \"Xigris is the brand name for drotrecogin alfa (activated)\", \"Xigris is the commercial form of drotrecogin alfa (activated) that was withdrawn\"]\n#######\nOutput:\n", "parameters": {"model": "gpt-4-turbo-preview", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": 1}, "history": null}